Does ivermectin shorten the length of sick time from COVID in adult outpatients? This question was answered by a controlled research study of non-hospitalized adults over age 30 with COVID.
There was no difference in length of illness nor rates of hospitalization in patients given ivermectin vs those given a placebo (inactive fake pill).
The bottom line: ivermectin was no better than a placebo in reducing illness time or severity of illness.
These results are helpful as another example of careful research evaluation of ivermectin in the treatment of COVID. So far, all of the research I have seen demonstrates that ivermectin is of no benefit for COVID patients.
Taking ivermectin for COVID is a complete waste of money.
Peter M. Hartmann, MD
Family Medicine & Psychiatry
